Living with Pulmonary Arterial Hypertension: Early Diagnosis, Patient Advocacy, and the Role of Technology
Co-authored by Maleen Fischer, PHA Europe
Breathing easier: tackling Alzheimer's through respiratory insights
At electronRx, we are constantly looking for ways we can leverage cutting-edge technology to redefine healthcare. We are excited about the potential of our work in pulmonary function and its connection to neurodegenerative diseases like Alzheimer's.
Personalising the patient experience
Co-authored by Jose Maria (Chema) Guido Avila, Sanofi
Challenges in the diagnosis and management of Asthma in children
Asthma is a common childhood respiratory condition, affecting around 14% of children worldwide [1]. Characteristic symptoms of asthma include wheezing, shortness of breath and coughing, usually triggered by exposure to certain allergens.
The innovation mirage: A deep tech perspective from CES 2025
There's something profoundly surreal about standing amidst humanity's technological frontier.
electronRx Reflects on CES 2025
CES, the Consumer Electronics Show, is the world's largest and most influential technology event, held annually in Las Vegas since 1967.
From caregivers to champions: supporting PAH patients and advocating for global accessibility
Co-authored by Gerald Fischer, PHA Europe
electronRx to launch purpleDx pulmonary disease smartphone app for remote lung function monitoring
Cardiopulmonary assessment tool detects and monitors digital biomarkers to support health management and help improve therapeutic outcomes for chronic respiratory disease patientselectronRx to showcase purpleDx at CES 2025 (7–10 Jan, Las Vegas)&
Strategies for coping with ILD
Interstitial lung disease (ILD) is a chronic and life-limiting lung disease with no curative options which can take a significant emotional toll on sufferers. A diagnosis of ILD comes with feelings of anxiety and uncertainty about the future.
COPD management: a critical look at gaps in pharmaceutical innovation
Chronic Obstructive Pulmonary Disease (COPD) presents a major global health challenge, marked by chronic respiratory decline and frequent exacerbations. Despite advances in treatment, comprehensive management strategies remain limited, revealing significant gaps in patient care.
Purpose-led collaboration in Pharma and HealthTech
Co-authored Samuel Hollis - Novartis
Science Partnered With Awareness Is Unstoppable
In this episode, Gerald and Maleen from PHA Europe join Dr Bipin Patel to share their experiences with Pulmonary Arterial Hypertension (PAH). They discuss the challenges of getting an accurate diagnosis, the importance of early detection, and the emotional and physical impacts of living with this rare disease.
Exploring the costs of asthma medication
Co-authored by Dr. Andrew Potter, Whaddon Medical Centre
Key challenges in the medical device startup landscape
Co-authored by Samantha Shelley, SQMS.
Maximizing the impact of chronic condition data collection
In the realm of healthcare, chronic conditions pose significant challenges for patients, caregivers, and healthcare providers alike. Effective management of chronic conditions requires a nuanced understanding of disease progression, treatment responses, and patient experiences.
Challenges and advances in asthma treatment
An In-depth Conversation with Dr. Andrew Potter of Whaddon Medical Centre
Transforming healthcare: the power of purpose-led partnerships
In this episode, Dr Bipin Patel sits down with Samuel Hollis, Coun
electronRx joins forces with PHA Europe to enhance life quality for pulmonary hypertension patients
Cambridge, UK – 23 September 2024 – electronRx, a leading digital medicine and biomarker expert, is excited to announce its sponsorship of PHA Europe in support of their vision of better quality of life and finding a cure for pulmonary hypertension (PH).
Living with ILD: A typical patient journey
Interstitial lung diseases (ILDs) are a group of disorders characterised by scarring and inflammation of the lung interstitium, common examples of which include idiopathic pulmonary fibrosis (IPF)and sarcoidosis.
From farms to factories: patient journey to Pulmonary Fibrosis
Rosemary’s health journey has been anything but straightforward. After enduring three years of painful breathing tests with countless visits to her GP and specialist consultants, she was finally given a diagnosis 12 months later—a name that escaped her when her granddaughter asked.
Transforming Healthcare: Navigating medical device regulations for startup success
In this episode we dive into medical device regulations with Sam Shelley, Quality Manager Consultant.
The role of Telehealth in managing chronic lung conditions
An In-depth Conversation with Dr. Andrew Potter of Whaddon Medical Centre
Transforming Healthcare Podcast— barriers to effective asthma care
In this special bonus episode, Dr.
lungDx Technology and ILD: White Paper
“Improperly treated ILD is associated with a poorer quality of life, an increased risk of life-threatening complications and early mortality.”